SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-023004
Filing Date
2020-05-07
Accepted
2020-05-07 17:16:47
Documents
76
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-10q_20200331.htm   iXBRL 10-Q 2499402
2 EX-31.1 dvax-ex311_11.htm EX-31.1 17835
3 EX-31.2 dvax-ex312_179.htm EX-31.2 17776
4 EX-32.1 dvax-ex321_16.htm EX-32.1 6087
5 EX-32.2 dvax-ex322_180.htm EX-32.2 6327
  Complete submission text file 0001564590-20-023004.txt   9689042

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dvax-20200331.xsd EX-101.SCH 64812
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dvax-20200331_cal.xml EX-101.CAL 65100
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dvax-20200331_def.xml EX-101.DEF 247586
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20200331_lab.xml EX-101.LAB 516280
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20200331_pre.xml EX-101.PRE 398977
13 EXTRACTED XBRL INSTANCE DOCUMENT dvax-10q_20200331_htm.xml XML 1967336
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 20857645
SIC: 2834 Pharmaceutical Preparations